The Post-Dobbs Abortion Pill Fight
Turn any article into a podcast. Upgrade now to start listening.
TL;DR
- Louisiana sued the FDA in October 2025 over a 2023 rule allowing mifepristone to be prescribed via telehealth and dispensed at retail pharmacies or mailed.
- The state argued the rule facilitated illegal abortions, as abortion is almost entirely banned in Louisiana.
- A conservative 5th Circuit Court of Appeals panel sided with Louisiana, staying the FDA's rule nationwide.
- Justice Samuel Alito issued an administrative stay reversing that ruling, restoring access while the Supreme Court considers emergency appeals.
- The case tests whether states with restrictive abortion laws can force federal regulators to alter national policy to aid enforcement of state bans.
- A win for Louisiana could allow its restrictive abortion laws to dictate medication access rules for the entire country.